Insider · CIK 0001816477

Del Carmen Jeffrey

Reports to the SEC for 1 company · CORAL GABLES, FL

sec.gov

Transactions

Companies

Filings

CIK

0001816477

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−107K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−14.3K sh	$31.50	−$452K	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−150K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−200K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−135K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−88K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−168K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−138K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−32.3K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−11.2K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−8,039 sh	—	—	0
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Commercial Officer	FTax Payment	−3,839 sh	—	—	14,337
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−8,667 sh	—	—	1,036,846
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+8,667 sh	—	—	18,176
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−8,039 sh	—	—	1,045,513
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+8,039 sh	—	—	12,001
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Commercial Officer	FTax Payment	−2,492 sh	—	—	9,509
2025-11-26	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+11K sh	—	—	1,053,552
2025-11-26	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+11K sh	$4.21	+$46.2K	14,945
2025-11-26	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Commercial Officer	SSale	−11K sh	$23.33	−$256K	3,962
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Commercial Officer	FTax Payment	−1,641 sh	—	—	3,962
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+5,603 sh	—	—	5,603
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−5,603 sh	—	—	1,064,535
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+32.3K sh	—	—	1,070,138
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Chief Commercial Officer	AAward	+107K sh	—	—	1,037,881
2025-03-03	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Commercial Officer	SSale	−30.4K sh	$22.89	−$696K	0
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−10.7K sh	—	—	931,008
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+10.7K sh	—	—	33,548
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Commercial Officer	FTax Payment	−3,125 sh	—	—	30,423
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Commercial Officer	FTax Payment	−3,839 sh	—	—	22,881
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+8,667 sh	—	—	26,720
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−8,667 sh	—	—	941,675
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−8,039 sh	—	—	950,342
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+8,039 sh	—	—	20,408
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Commercial Officer	FTax Payment	−2,355 sh	—	—	18,053
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Chief Commercial Officer	AAward	−138K sh	—	—	941,572
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	−16.8K sh	—	—	958,381
2024-08-09	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−30K sh	—	—	804,019
2024-08-09	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Commercial Officer	SSale	−6,058 sh	$18.44	−$112K	12,369
2024-08-09	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+30K sh	$2.86	+$85.8K	42,369
2024-08-09	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Commercial Officer	SSale	−30K sh	$18.42	−$553K	12,369
2024-06-07	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Commercial Officer	SSale	−7,541 sh	$16.07	−$121K	18,427
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Commercial Officer	FTax Payment	−3,125 sh	—	—	25,968
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−10.7K sh	—	—	834,019
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+10.7K sh	—	—	29,093
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Commercial Officer	FTax Payment	−3,839 sh	—	—	18,426
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+8,666 sh	—	—	22,265
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−8,666 sh	—	—	844,686
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+24.1K sh	—	—	853,352
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Chief Commercial Officer	AAward	+168K sh	—	—	829,235

Recent filings

Accepted (ET)
Jul 174
Del Carmen Jeffrey0001161697-26-000174
SEC(opens sec.gov)
Dec 304
Del Carmen Jeffrey0001161697-25-000489
SEC(opens sec.gov)
Dec 104
Del Carmen Jeffrey0001161697-25-000443
SEC(opens sec.gov)
Nov 284
Del Carmen Jeffrey0001161697-25-000430
SEC(opens sec.gov)

Companies

CATALYST PHARMACEUTICALS, INC.Chief Commercial OfficerCPRX

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134